Thomas P Davis

  • 10892 Citations
  • 55 h-Index
1978 …2021
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1978 2019

  • 10892 Citations
  • 55 h-Index
  • 252 Article
  • 10 Chapter
  • 2 Review article
  • 1 Short survey
Filter
Chapter
2017
2 Citations (Scopus)

Development and Maintenance of the Blood-Brain Barrier

Herndon, J. M., Tome, M. E. & Davis, T. P., Mar 7 2017, Primer on Cerebrovascular Diseases: Second Edition. Elsevier Inc., p. 51-56 6 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Blood-Brain Barrier
Maintenance
Pericytes
Microglia
Astrocytes

Mechanisms of Endothelial Injury and Blood-Brain Barrier Dysfunction in Stroke

Ronaldson, P. T. & Davis, T. P., Mar 7 2017, Primer on Cerebrovascular Diseases: Second Edition. Elsevier Inc., p. 220-226 7 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Blood-Brain Barrier
Stroke
Brain Injuries
Wounds and Injuries
Tight Junction Proteins
2013

Opioid Peptides

Egleton, R. D., Witt, K. A. & Davis, T. P., 2013, Handbook of Biologically Active Peptides. Elsevier Inc., p. 1696-1701 6 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Opioid Peptides
2008

CNS drug delivery: Opioid peptides and the blood-brain barrier

Witt, K. A. & Davis, T. P., 2008, Drug Addiction: From Basic Research to Therapy. Springer New York, p. 511-533 23 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Central Nervous System Agents
Opioid Peptides
Blood-Brain Barrier
Peptides
Pain
2006
1 Citation (Scopus)

Opiate Peptides And The Blood-Brain Barrier

Egleton, R. D., Witt, K. A. & Davis, T. P., 2006, Handbook of Biologically Active Peptides. Elsevier Inc., p. 1429-1434 6 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Opioid Peptides
Blood-Brain Barrier
Peptides
Neurology
Pain
2005
2 Citations (Scopus)

Molecular modulation of the blood-brain barrier during stroke

Fleegal, M. A., Hom, S. & Davis, T. P., Jan 1 2005, The Blood-Brain Barrier and its Microenvironment: Basic Physiology to Neurological Disease. CRC Press, p. 387-407 21 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Blood-Brain Barrier
Stroke
Research
Neurons
Civilization
2003

Peptides and the Blood-Brain Barrier: Enhancing Peptide Bioavailability to the Brain

Egleton, R. D., Witt, K. A. & Davis, T. P., Nov 21 2003, Blood-Spinal Cord and Brain Barriers in Health and Disease. Elsevier Inc., p. 107-115 9 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Blood-Brain Barrier
Biological Availability
Peptides
Brain
Nervous System Diseases
1982
2 Citations (Scopus)

Bisantrene (B) and mitoxantrone (M) physiochemical properties and in vitro metabolism by a rapid HPLC analysis

Peng, Y. M., Ormberg, D., Davis, T. P. & Alberts, D. S., 1982, Proceedings of the American Association for Cancer Research. Vol. Vol. 23.

Research output: Chapter in Book/Report/Conference proceedingChapter

bisantrene
Mitoxantrone
High Pressure Liquid Chromatography
In Vitro Techniques
1 Citation (Scopus)

Comparative pharmacology of mitoxantrone and bisantrene

Alberts, D. S., Yei Mei Peng, M. P. & Davis, T. P., 1982, Proceedings of the American Association for Cancer Research. Vol. Vol. 23. p. 491 1 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

bisantrene
Mitoxantrone
Pharmacology
1981

High performance liquid chromatography (HPLC) of 9, 10-anthracenedicarboxaldehyde bis [4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride (ADCA)----physicochemical properties and pharmacokinetics

Peng, Y. M., Alberts, D. S., Davis, T. P. & Wood, D., 1981, Proceedings of the American Association for Cancer Research. Vol. Vol. 22. p. 606 1 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

bisantrene
Pharmacokinetics
High Pressure Liquid Chromatography